Table 7.
Previously reported cases of cytoplasmic body myopathy with early respiratory failure
Author, year | N | Onset age (years) | Myopathy characteristics | Other clinical features | Neurophysiology | Pathologic features | Outcome | Inheritance, linkage region |
---|---|---|---|---|---|---|---|---|
Kinoshita, 1975 | 1 | 16 |
|
Micrognathia, cleft palate | EMG: myopathic changes | Inclusions in muscle fibre periphery. Thickened Z-discs and disorganized myofibrillar material | Death at 23 years from RF | Sporadic, N/A |
Jerusalem, 1979 | 1 | Childhood | Respiratory, axial and shoulder muscle weakness | EMG: active neurogenic changes | Numerous cytoplasmic bodies in type I fibres. Endoplasmic reticulum dilations in axons | Death at 31 years from RF | Sporadic, N/A | |
Patel, 1983 | 3 | Childhood |
|
Scoliosis, dysmorphic features, cardiac hypertrophy and conduction defects, constipation | EMG: myopathic changes | Cytoplasmic bodies predominant in type I fibres |
|
Autosomal dominant or recessive, N/A |
Winter, 1986 | 1 | 25 | Respiratory and proximal muscle weakness | Polydactyly, neck stiffness |
|
Eosinophilic cytoplasmic bodies, mainly in type I fibres and internal nuclei | Requiring intermittent positive pressure ventilation at night | Sporadic, N/A |
Chapon, 1989 | 3 | 18, 40, 44 | Respiratory, axial and proximal weakness | Mild cardiac hypokinesis in one patient | EMG: myopathic changes. | Cytoplasmic bodies in type I fibres | Autosomal dominant, N/A | |
Edstrom, 1990 | 16 (3 families) | 14–50 | Respiratory, proximal and sternomastoid weakness | EMG: myopathic changes | Myofibrillar lesions in Z-disks and distributed filamentous masses. Cytoplasmic bodies | Autosomal dominant, 2q24-31, R279W TTN mutation (Lange, 2005) | ||
Bertini, 1990 | 1 | 1 | Respiratory failure, bulbar/neck flexor weakness | Hyporeflexia | EMG: myopathic changes | Inclusions with positive immunostaining for desmin and actin | Death at 14 months from RF | Sporadic |
Abe, 1993 | 5 | 35–48 | Respiratory and distal muscle weakness, worst in tibialis anterior | Weight loss, finger contractures | EMG: myopathic changes, slight neurogenic changes | Eosinophilic inclusions. Cytoplasmic bodies predominantly in type I fibres | Early death from RF in some family members | Autosomal dominant, N/A |
Baeta, 1996 | 1 | 67 | Respiratory failure (limited clinical information) | Cardiomyopathy | Cytoplasmic bodies predominantly in type I fibres | Autosomal dominant, N/A | ||
Evangelista, 2009 | 1 | 74 | Hip flexor weakness, respiratory fatigue | Symptoms provoked by HMG-CoA reductase inhibitor therapy and improved with cessation |
|
Eosinophilic inclusions (termed as cytoplasmic bodies but no EM analysis) | Resolution with cessation of HMG CoA reductase inhibitor | Sporadic, N/A |
Tasca, 2010 | 1 | 32 | Respiratory failure, neck flexor, hip flexor, hip flexor, tibialis anterior, peroneal weakness. Scapular winging and nasal voice | Eosinophilic inclusions. Diffuse IHC staining for sarcoplasmic proteins. Cytoplasmic bodies on EM. Z-line abnormalities | Sporadic, N/A (R279W TTN mutation was excluded) | |||
Chinnery, 2001; Birchall, 2005; current study | 31 (3 families) | 22–71 | Respiratory failure, proximal and/or distal muscle weakness, some patients with neck flexor weakness | EMG: myopathic and active neurogenic changes | Eosinophilic inclusions, some rimmed vacuoles, no fibre-type predominance. No cytoplasmic bodies on EM | Slowly progressive course. Early death from RF in one patient. Night-time CPAP and walking aids for several family members | Autosomal dominant, 2q24-31, p.Cys30071Arg TTN mutation |
CPAP = continuous positive airway pressure; EM = electron microscopy; EMG = electromyography; IHC = immunohistochemistry; NCS = nerve conduction studies; RF = respiratory failure; M = male; F = female; HMG-CoA = 3-hydroxy-3-methyl-glutaryl-coenzyme A.